Sign In
Get Clay Free →

Suggestions

    Austin Walters

    Venture Capitalist and Entrepreneur

    Austin Walters is the Co-Founder and Chief Research Officer (CRO) of Edilytics, a company that builds precision algorithms for analyzing genome editing experimental data and provides computational support for processing next-generation sequencing data.1

    Some key facts about Austin Walters:

    • He is the Founder & Managing Partner at SpringTide Ventures, a venture capital firm that invests in healthcare companies.1
    • He has experience as an investor and board director for several healthcare startups, including Prolucent Health, Vigor, and PathologyWatch.1
    • He holds an MBA from Harvard Business School and has a background in management consulting, working with Fortune 500 companies on disruptive innovation.1
    • His LinkedIn username is acwalters.1

    So in summary, Austin Walters is an experienced healthcare entrepreneur, investor and executive who co-founded Edilytics to apply computational biology to genome editing research. He is also the founder of SpringTide Ventures, a venture capital firm focused on healthcare innovation.

    Highlights

    Apr 20 · biorxiv.org
    Suppression of bacterial cell death underlies the antagonistic ...

    Related Questions

    What inspired Austin Walters to co-found Edilytics?
    How did Austin Walters' experience at Harvard Business School influence his career?
    What are some of the key projects Austin Walters has worked on at SpringTide Ventures?
    How does Austin Walters' background in international relations and Russian influence his work in healthcare and technology?
    What are the main goals of Edilytics, and how does Austin Walters contribute to them?
    Austin Walters
    Austin Walters, photo 1
    Austin Walters, photo 2
    Get intro to Austin
    Add to my network

    Experience

    Founder & Managing Partner at SpringTide Ventures (January 2018 - Present)
    Co-Founder and CRO at Edilytics (October 2019 - Present); Investor & Board Director at Prolucent Health, Vigor, PathologyWatch; Seed Investor at Great Expectations, Commercial Director at EchoNous Inc. (2016 - February 2017); Analyst at Innosight (November 2009 - August 2011); Researcher at Harvard Law School and Brigham Young University

    Education

    MBA in Entrepreneurship, Healthcare, Emerging Markets, Venture Capital from Harvard Business School (2012 - 2016); BA in International Relations, Russian from Brigham Young University (2005 - 2009)

    Location

    Cambridge, Massachusetts, United States